AACC 2019 | Cystatin C Immunoassay | PETIA | Gentian Diagnostics
medical, diagnostics, immunoassays, assays, in vitro diagnostics, IVD products, avian antibodies, antibodies, clinical chemistry, diagnostic tests, biotechnology
post-template-default,single,single-post,postid-19221,single-format-standard,bridge-core-1.0.6,ajax_fade,page_not_loaded,,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-18.2,qode-theme-bridge,wpb-js-composer js-comp-ver-6.0.5,vc_responsive

Cystatin C at AACC 2019

AACC 2019 - Cystatin C

Cystatin C at AACC 2019

learn more about cystatin c at AACC 2019

Cystatin C is a superior kidney marker and can be used to estimate GFR for all patients independently of gender, weight, muscle mass, and age if patient is older than 2 years. Cystatin C is recommended by KDIGO and NCIS (1,2)

Particle-Enhanced Turbidimetric Immunoassay (PETIA)

The Gentian Cystatin C Immunoassay is a Particle-Enhanced Turbidimetric Immunoassay (PETIA) for in vitro diagnostic testing of cystatin C in human plasma and serum samples. It performs rapidly in only 10 minutes.

FDA510(k) cleared and CE-marked

The Gentian Cystatin C Immunoassay is FDA510(k) cleared and CE-marked. It is one of the methods selected to evaluate the commutability of the World standard procedure by IFCC [3] (ERM-DA471/IFCC standardised).

Learn more about Cystatin C at AACC

Cystatin C on a wide range of analysers

The immunoassay can be applied on a wide range of clinical chemical analysers with documented high inter instrument accuracy [4].

Examples of instruments

Siemens Healthcare: ADVIA®

Abbott Laboratories: ARCHITECT®

Beckman Coulter: AU®

Ortho Clinical Diagnostics: VITROS®

Mindray: BS®


[1] O.Z. Ismail, et al., 2017, http://dx.doi.org/10.1016/j.clinbiochem.2017.01.005 2

[2] Tangri N, et al Kidney Int 2011;79:471-7

[3] Grubb A et al, Clin Chem Lab Med 2010;48: 16-19

[4] Eckfeldt JH, et al. 2014 CYS Survey. Arch Pathol Lab Med 2015;139:888-93.